FDA Status
Not FDA-Approved (US)
Approved in Russia
Claimed Benefits
- Stroke rehabilitation
- Acute CNS activity enhancement
- Quality of life in motor neuron disease
Clinical Evidence
4
Human Trials
Approved (Russia)
Highest Phase
Two clinical trials in acute ischemic stroke demonstrated neuroprotection, elevated BDNF, and faster functional recovery.
Read Full Deep Dive
Mechanism, dosing, vendor pricing, and full research citations